Hidas Guy, Lupinsky Liad, Kastin Alexander, Moskovitz Boaz, Groshar David, Nativ Ofer
Department of Urology, Bnai-Zion and Medical Center, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Eur Urol. 2007 Sep;52(3):785-9. doi: 10.1016/j.eururo.2006.12.001. Epub 2006 Dec 11.
To compare changes in renal function following nephron-sparing surgery (NSS) using tissue adhesive only versus NSS using standard suturing technique, as measured by quantitative SPECT of 99m Tc-dimercaptosuccinic acid uptake by the kidney (QDMSA).
QDMSA was done before and 3-6 mo after the operation in 32 patients who underwent standard suturing technique and in 24 patients in whom tissue adhesive sealant (19 with albumin glutaraldehyde tissue adhesive [BioGlue]; 5 with CoSeal) was used to close the parenchymal defect. Individual kidney uptake was measured and retrospectively compared between the two groups.
Average tumor diameter was 3.4cm (range: 2.2-6) in the suture group and 3.56 (range: 1.7-6) in the tissue sealant group. In the tissue sealant group following surgery, we observed an average individual renal function loss of 11.49% compared with the suture group in whom an average individual renal function loss of 20.36% (p = 0.02) was measured by 99m Tc-DMSA.
The use of tissue sealant to close the parenchymal defect during NSS demonstrated a statistically significant advantage in reducing functioning renal loss as measured by the absolute uptake of QDMSA. Further clinical studies are required to establish the role of tissue sealants in NSS.
通过用肾脏对99m锝-二巯基丁二酸摄取量的定量单光子发射计算机断层扫描(QDMSA)来比较仅使用组织粘合剂的保留肾单位手术(NSS)与使用标准缝合技术的NSS术后肾功能的变化。
对32例行标准缝合技术的患者和24例使用组织粘合剂封闭实质缺损的患者(19例使用白蛋白戊二醛组织粘合剂[BioGlue];5例使用CoSeal)在手术前及术后3至6个月进行QDMSA检查。测量并回顾性比较两组的单个肾脏摄取情况。
缝合组的平均肿瘤直径为3.4厘米(范围:2.2 - 6厘米),组织粘合剂组为3.56厘米(范围:1.7 - 6厘米)。在组织粘合剂组术后,通过99m锝-二巯基丁二酸测定,我们观察到单个肾功能平均损失为11.49%,而缝合组单个肾功能平均损失为20.36%(p = 0.02)。
在保留肾单位手术中使用组织粘合剂封闭实质缺损,在通过QDMSA的绝对摄取量测量减少功能性肾损失方面显示出统计学上的显著优势。需要进一步的临床研究来确定组织粘合剂在保留肾单位手术中的作用。